Implementation of hepatitis C cure in Australia: one year on

Implementation of hepatitis C cure in Australia: one year on

Objectives: Direct-acting antivirals (DAAs) for the treatment of hepatitis C (HCV) became universally available in Australia in March 2016, with an aim to achieve HCV elimination. Fourteen per cent of Australians with HCV have initiated treatment. The objective of this study was to explore and ident...

Full description

Bibliographic Details
Main Authors:	Jacqueline A. Richmond, Jack Wallace
Format:	Article
Language:	English
Published:	Elsevier 2018-04-01
Series:	Journal of Virus Eradication
Subjects:	Australia, elimination, hepatitis C, implementation, treatment
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020302545

Similar Items

Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian ‘surveillance and treatment of prisoners with hepatitis C’ project (SToP-C)
by: Jake Rance, et al.
Published: (2021-04-01)

The Evolution of Hepatitis C Treatment
by: Masoomeh Sofian
Published: (2018-10-01)

A micro-elimination approach to addressing hepatitis C in Turkey
by: Ramazan Idilman, et al.
Published: (2020-03-01)

Eliminating viral hepatitis C in Belgium: the micro-elimination approach
by: Dana Busschots, et al.
Published: (2020-02-01)

Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access
by: Nick Scott, et al.
Published: (2018-04-01)

The case for a universal hepatitis C vaccine to achieve hepatitis C elimination
by: Nick Scott, et al.
Published: (2019-09-01)

Experiences of diagnosis, care and treatment among Aboriginal people living with hepatitis C
by: Loren Brener, et al.
Published: (2016-04-01)

Elimination of Hepatitis C in Portugal: An Urban Legend?
by: José Velosa, et al.
Published: (2020-02-01)

Meeting measles elimination indicators: surveillance performance in a regional area of Australia
by: David N Durrheim, et al.
Published: (2011-08-01)

Sustained outbreak of measles in New South Wales, 2012: risks for measles elimination in Australia
by: Zeina Najjar, et al.
Published: (2014-01-01)

The role of the Primary Healthcare Network in Iran in hepatitis C virus elimination by 2030
by: Masoud Behzadifar, et al.
Published: (2018-07-01)

The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review
by: Christina Greenaway, et al.
Published: (2018-09-01)

Possible Strategies for the Implementation of who Program on the Elimination of Hepatitis C in Ukraine by 2030
by: I. Zaytsev, et al.
Published: (2018-06-01)

Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data
by: David C. Boettiger, et al.
Published: (2017-12-01)

Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework
by: Ste.phanie Popping, et al.
Published: (2018-07-01)

A decentralised, multidisciplinary model of care facilitates treatment of hepatitis C in regional Australia
by: Andrew Lee, et al.
Published: (2018-07-01)

Estimating regional prevalence of chronic hepatitis C with a capture-recapture analysis
by: Patricia A. M. Kracht, et al.
Published: (2021-07-01)

Hepatitis C Virus Prevalence and Risk Factors in a Village in Northeastern Romania—A Population-Based Screening—The First Step to Viral Micro-Elimination
by: Laura Huiban, et al.
Published: (2021-05-01)

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach
by: Blach, S., et al.
Published: (2022)

Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal
by: Christoph Sarrazin, et al.
Published: (2021-06-01)

The distribution and socioeconomic burden of Hepatitis C virus in South Australia: a cross-sectional study 2010–2016
by: Bernard Luke Edmunds, et al.
Published: (2019-05-01)

Under one roof: identification, evaluation, and treatment of chronic hepatitis C in addiction care
by: Stephen A. Martin, et al.
Published: (2018-04-01)

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C
by: Stephanie Popping, et al.
Published: (2018-07-01)

Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
by: Sanam Hariri, et al.
Published: (2020-10-01)

Autochthonous and Travel Acquired Hepatitis E Virus in Australia
by: Jacinta O’Keefe, et al.
Published: (2021-02-01)

Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits
by: Nick Scott, et al.
Published: (2021-05-01)

Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure
by: Mir F, et al.
Published: (2017-02-01)

Judicial implementation of the administrative decision
by: lumaa qibi
Published: (2019-12-01)

Towards the elimination of viral hepatitis in Thailand by the year 2030
by: Nawarat Posuwan, et al.
Published: (2020-09-01)

Viral hepatitis B and C. Cure or treatment?
by: Dimitrios A. Kountouras
Published: (2014-12-01)

French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long
by: Cécile Brouard, et al.
Published: (2020-10-01)

Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019
by: Anna Maisa, et al.
Published: (2021-05-01)

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals
by: Stephanie Popping, et al.
Published: (2019-01-01)

The Key Role of Non-governmental Organizations (NGOs) Activities in Viral Hepatitis Elimination Programs
by: Farzaneh Padami, et al.
Published: (2019-03-01)

Hepatitis E Virus and Implications for Blood Supply Safety, Australia
by: Ashish C. Shrestha, et al.
Published: (2014-11-01)

Elimination of Hepatitis B in Highly Endemic Settings: Lessons Learned in Taiwan and Challenges Ahead
by: Chun-Jen Liu, et al.
Published: (2020-07-01)

A study of pharmacogenomics for therapeutic and prognostic guidance towards hepatitis C virus (HCV) for patients co-infected with HIV
by: Yuen, King-tai, et al.
Published: (2014)

Health Sector Response to Viral Hepatitis in the Selected Countries
by: Mohamad Ezati Asar, et al.
Published: (2018-04-01)

Public Health Unit notifications of hepatitis C and their follow-up in South Western Sydney, Australia
by: Elizabeth R O'Brien, et al.
Published: (2021-09-01)

Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination
by: Liesl M. Hagan, et al.
Published: (2019-05-01)